Back to search

National and Kapodistrian University of Athens

Pathogenetic mechanisms and cell subpopulations in the inflammatory response of systemic vasculitides

Abstract

dc:description

Introduction: Giant cell arteritis (GCA) and Polymyalgia Rheumatica (PMR) are autoimmune/autoinflammatory disorders presenting as acute inflammatory responses that are highly responsive to steroids. GCA is an autoimmune disease affecting large vessels in patients over 50 years old. It is an exemplary model of a classic inflammatory disorder with IL-6 playing the leading role. The main comorbidities that may appear acutely or chronically are vascular occlusion leading to blindness and thoracic aorta aneurysm formation, respectively. The tissue inflammatory bulk is expressed as acute or chronic delayed-type hypersensitivity reactions, the latter being apparent by giant cell formation. The activated monocytes/macrophages are associated with pronounced Th1 and Th17 responses. B-cells and neutrophils also participate in the inflammatory lesion. However, the exact order of appearance and mechanistic interactions between cells are hindered by the lack of cellular and molecular information from early disease stages and accurate experimental models. Furthermore, clinical unmet needs include the lack of biomarkers associated with the assessment of disease activity and response to treatment, while patients may still experience disease relapse or adverse disease comorbidities (i.e., aneurysm formation) even after modern treatments such as biologic agents (i.e., tocilizumab, mavrilimumab) indicating that current targeted treatments may fail to control disease progression. Objectives: The current thesis aims to: A. To explore the presence of neutrophil extracellular traps (NETs) in inflamed temporal artery biopsies (TABs) of patients with GCA. B. To identify novel soluble serum biomarkers in PET/CT-positive patients with LV-GCA and associate them with active (0 months) and inactive disease (6 months following treatment), in sequential serum samples, and C. To decipher the immune landscape including immune cell subpopulations, plasma cytokines, and small lipid mediators (LMs) at the very early stages of steroid treatment initiation in 4 distinct time points at: 0h (T1), 48h (T2), 96h (T3), and 24 weeks (T4).Patients and Methods: A. Ten patients with GCA [five with limited and five with associated generalized vascular involvement, as defined by 18F-fluorodeoxyglucose PET with CT (PET/CT)] and eight with PMR were studied. The presence, location, quantitation, and decoration of NETs with IL-6, IL-1b, and IL-17A were assessed in TABs at the time of disease diagnosis by tissue immunofluorescence and confocal microscopy. Paired serum levels of IL-6 and IL-17A were also evaluated in all patients. B. 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET-CT) is among the imaging techniques contributing to the diagnosis of patients with systemic disease. The PET/CT derived metric, Most-Disease-Segment Target-to-Background Ratio (TBRMDS), was calculated for 13 LV-GCA patients, while 14 cranial-GCA and 14 Polymyalgia Rheumatica patients with negative initial PET/CT served as disease controls. Serum macrophage-related cytokines were evaluated by Cytometric Bead Array (CBA). Finally, previously published NMR-metabolomics data acquired from the same blood sampling were analyzed along with PET/CT findings. C. Serum, plasma, and peripheral blood mononuclear cells (PBMCs) were collected prospectively from 8 GCA and 6 PMR newly diagnosed patients. Sixteen healthy individuals served as controls (HC). Deep immunophenotyping by CyTOF was performed in PBMCs at T1-T3. A multiplexed Luminex assay measured serum levels of 21 cytokines at T1 and T3. Lipid mediators (LMs) levels were evaluated at T1, T3, and T4 with the LC-MS/MS method. Results: A. NETs were detected in all TABs from GCA, but not PMR, patients that located mainly in the adventitia, adjacent to the vasa vasorum. NETs decorated with IL-6 were present in 8/10 TABs of GCA patients, of whom 5 were PET/CT(+) and 3 were PET/CT(–) patients. IL-17A(+) NETs were observed in all GCA patients. IL-1b(+) NETs were not detected in any GCA patient. No relation was found between serum IL-6 and IL-17A levels and NETs containing IL-6 and/or IL-17A.B. TBRMDS was significantly increased in active versus inactive disease (3.32 vs. 2.65, p = 0.006). The analysis identified 9 serum metabolites, as more sensitive to change from the active to inactive disease states. Among them, choline levels were exclusively altered in the LV-GCA group, but not in the disease control group. Cytokine levels were not associated with PET/CT activity. Combining CRP, ESR, and TBRMDS with choline levels, a composite index was generated to distinguish active and inactive LV-GCA (20.4 vs 11.62, p=0.001).C. Total CD8+ T cells and DCs were decreased within 48-96 hours, following steroid treatment, while B-cells were increased at 48 hours. Further analysis of immune subpopulations containing the major cell types revealed different frequencies of distinct CD8+, CD4+, DCs, and B cell subtypes. Out of 21 cytokines/chemokines evaluated, only ITAC levels were decreased at T3. The ratio of pro/anti-inflammatory LMs was high at T1 in patients with either PMR or GCA. However, 6 months after steroid treatment it returned to normal in PMR patients, but remained high in GCA patients, providing the only discriminatory element between the two diseases. Conclusions: A. NETs bearing pro-inflammatory cytokines are present in inflamed GCA-TABs. Future studies with a larger number of patients from different centers will show whether the findings regarding neutrophils/NETs in the TAB are consistent and disclose their clinical impact. B. The preliminary results of the current thesis on serum biomarkers associated with clinical data could pave the way for more extensive studies integrating serum metabolomic parameters with PET/CT imaging data to extract sensitive composite disease indexes useful for everyday clinical practice. C. The rapid clinical improvement of GCA and PMR patients following steroid treatment, is associated with immune cell type alterations, but it is poorly associated with plasma cytokine levels. Small lipid mediators can differentiate GCA and PMR patients. The persistently elevated levels of pro-inflammatory LMs might be related to the underlying residual tissue inflammation described in GCA. These preliminary results suggest that further studies in a larger patient cohort are required to validate these findings and identify new therapeutic targets and/or disease-specific biomarkers.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Palamidas, Dimitrios-Anastasios
  • Παλαμήδας, Δημήτριος-Αναστάσιος

Subjects

dc:subject × 18

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58940

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Palamidas, Dimitrios-Anastasios; Παλαμήδας, Δημήτριος-Αναστάσιος. Pathogenetic mechanisms and cell subpopulations in the inflammatory response of systemic vasculitides. National and Kapodistrian University of Athens, 2025. http://hdl.handle.net/10442/hedi/58940